Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00540371 · ClinicalTrials.gov registry record
Dynamic Epidermal Cooling During Pulsed Dye Laser Treatment of Port Wine Stain Birthmark at High Fluences
A clinical trial of Port-Wine Stain, sponsored by University of California, Irvine.
- Completed
- Registry status
- 136
- Enrollment target
- 1
- Study location
NCT00540371: Completed study of Port-Wine Stain, sponsored by University of California, Irvine.
NCT00540371 is a study of Port-Wine Stain that has completed, run by University of California, Irvine. The registered enrollment target is 136 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00540371, a study of Port-Wine Stain, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 136 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to improve the efficacy of pulsed dye laser treatment of port wine stain birthmarks. Involvement in the protocol will involve formal documentation of the level of treatment pain, duration of post-treatment purpura and incidence of side effects. In addition, measurements will be taken of blood substances that promote blood vessel formation/regrowth and non-invasive reflectance measurements and photographs will be taken before and after treatment. The objective of this study is to document the degree of port wine stain lightening, the incidence of side effects and the presence of angiogenic factors induced during treatment with the pulsed dye laser in association with cooling agent. This information ultimately lead to improved treatment.
Conditions Studied
Interventions
- OTHER Port wine stain Birthmark
Study Locations (1)
California
- Beckman Lase Institute Medical Clinic Unversity of California Irvine - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 1999-12 |
| Est. Completion | 2009-02 |
What the finished NCT00540371 record still lists
NCT00540371 is an observational study that tracks outcomes without assigning an intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Port-Wine Stain appearing as the primary indexed condition, and to 1 intervention - of which Port wine stain Birthmark is the first listed.
NCT00540371 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00540371 about?
NCT00540371 is a clinical study titled "Dynamic Epidermal Cooling During Pulsed Dye Laser Treatment of Port Wine Stain Birthmark at High Fluences". The purpose of the study is to improve the efficacy of pulsed dye laser treatment of port wine stain birthmarks. Involvement in the protocol will involve formal documentation of the level of treatment pain, duration of post-treatment purpura and incidence of side effects. In addition, measurements w...
What is the current status of trial NCT00540371?
This trial is currently completed. The enrollment target is 136 participants. The study started on 1999-12. Estimated completion is 2009-02.
What conditions does trial NCT00540371 study?
This clinical trial studies the following conditions: Port-Wine Stain.
What interventions are being tested in trial NCT00540371?
The interventions under investigation include: Port wine stain Birthmark (OTHER).
Who is sponsoring clinical trial NCT00540371?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00540371 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Port-Wine Stain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01555892 · 136 participants · Phase 1
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
- NCT03216525 · 136 participants · Phase 3
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
- NCT04476901 · 136 participants · Phase 2
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
- NCT04603898 · 136 participants · NA
Oxalate Formation From Ascorbic Acid
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia